
Myc and mTOR converge on a common node in protein synthesis …
Jul 16, 2013 · Here, we uncover a surprising and important functional link between Myc and mammalian target of rapamycin (mTOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 (4EBP1), a master regulator of protein synthesis control.
A functional mTORC1 signaling is indispensable for c-Myc driven ...
Here, we demonstrate that the mammalian target of rapamycin complex 1 (mTORC1) cascade is activated and necessary for c-Myc dependent hepatocarcinogenesis. Specifically, we found that ablation of Raptor, the unique member of the mTORC1 complex, strongly inhibits c-Myc liver tumor formation.
MYC is a clinically significant driver of mTOR inhibitor ... - PubMed
Aug 29, 2023 · Here, we show that MYC activation drives resistance to mTOR inhibitors (mTORi) in breast cancer. Multiomic profiling of mouse invasive lobular carcinoma (ILC) tumors revealed recurrent Myc amplifications in tumors that acquired resistance to the mTORi AZD8055.
MYC is a clinically significant driver of mTOR inhibitor resistance …
Here, we show that MYC activation drives resistance to mTOR inhibitors (mTORi) in breast cancer. Multiomic profiling of mouse invasive lobular carcinoma (ILC) tumors revealed recurrent Myc amplifications in tumors that acquired resistance to the mTORi AZD8055.
mTOR inhibition suppresses Myc-driven polyposis by inducing
May 3, 2023 · Myc is a key driver of colorectal cancer initiation and progression, but remains a difficult drug target. In this study, we show that mTOR inhibition potently suppresses intestinal polyp...
Regulation of cancer cell metabolism: oncogenic MYC in the
Jul 10, 2020 · Transcription factors of the MYC family are deregulated in up to 70% of all human cancers through a variety of mechanisms. Oncogenic levels of MYC regulates almost every aspect of cellular...
mTORC1-c-Myc pathway rewires methionine metabolism for HCC …
Nov 12, 2022 · Here, we investigated the role of mTORC1-c-Myc-SIRT4 axis in the regulating methionine metabolism by using tumour derived cell lines, mouse models and human specimens. First, we found that c-Myc acted as downstream of mTORC1 signaling pathway in …
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC ...
Cancer treatments often require combinations of molecularly targeted agents to be effective. mTORi (rapamycin) and HDACi (MS-275/entinostat) inhibitors have been shown to be effective in limiting tumor growth, and here we define part of the cooperative action of this drug combination.
Myc and mTOR converge on a common node in protein synthesis ... - PNAS
May 31, 2013 · Here, we uncover a surprising and important functional link between Myc and mammalian target of rapamycin (mTOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 (4EBP1), a master regulator of protein synthesis control.
Myc and mTOR converge on a common node in protein synthesis …
May 31, 2013 · Here, we uncover a surprising and important functional link between Myc and mammalian target of rapamycin (mTOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 (4EBP1), a master regulator of protein synthesis control.
- Some results have been removed